What we cover
Diagnostics
What this beat covers
How the tests themselves work, what the numbers on the sheet mean, and where the design of routine care and the interests of an individual reader diverge.
A standard panel is very good at what it was built for: finding disease cheaply across a whole population. It was never built to characterise where a well person stands, and asking it to do that is where most of the confusion originates.
Reference ranges, plainly
Most ranges are constructed by measuring a reference population and reporting the middle 95 percent. If that population includes a large number of adults with undiagnosed metabolic dysfunction — and in the United States it does — then "in range" and "in good shape" are not the same statement, and never were.
This is also why a value can move substantially year over year, in a direction anyone would find concerning, and never trigger a flag. Nothing in the system is watching the slope.
The measures
What we write about in this area
- The standard panel itself
- What a CMP, lipid panel and CBC actually cover, and what they leave out.
- High-sensitivity CRP
- A general inflammation marker: non-specific, which is a real limitation, but worth pursuing when persistently elevated.
- Thyroid beyond TSH
- A single value standing in for a system with several moving parts.
- Vitamin D, B12, ferritin, homocysteine
- Individually unremarkable, collectively often the explanation for how somebody feels.
- Genetic markers measured once
- MTHFR, APO-E and Lp(a) do not need repeating, which changes how to think about their cost.
Questions we keep coming back to
- When does more measurement start producing more harm than information?
- How should a reader weigh screening guidance written for populations against their own situation?
- What is the shortest list of additions that would meaningfully improve a standard panel?
We work through these continuously. The Coastline Brief is where the answers land first.